Integra Lifesciences (NASDAQ:IART) reported Q4 2017 earnings this Morning, coming in at $0.64 per share, beating Wall Street’s estimates of $0.56 per Share. Revenue for the quarter came in at $368.60 million beating analyst estimates of $362.64 million Recent Insider Trading for Integra Lifesciences (NASDAQ:IART)
- On 11/20/2017 Jeffrey Mosebrook, Insider, sold 160 with an average share price of $47.41 per share and the total transaction amounting to $7,585.60.
- On 11/14/2017 Richard D Gorelick, VP, sold 1,500 with an average share price of $47.19 per share and the total transaction amounting to $70,785.00.
- On 10/31/2017 Barbara B Hill, Director, bought 10,768 with an average share price of $46.66 per share and the total transaction amounting to $502,434.88.
- On 8/4/2017 Donald E Morel Jr, Director, bought 10,000 with an average share price of $49.25 per share and the total transaction amounting to $492,500.00.
- On 8/3/2017 Donald E Morel Jr, Director, bought 2,500 with an average share price of $49.29 per share and the total transaction amounting to $123,225.00.
- On 8/1/2017 Barbara B Hill, Director, bought 5,050 with an average share price of $49.33 per share and the total transaction amounting to $249,116.50.
Recent Trading for Integra Lifesciences (NASDAQ:IART) Shares of Integra Lifesciences closed the previous trading session at 53.25 down -1.71 3.11% with 54.54999923706055 shares trading hands.